Cymabay Therapeutics (NASDAQ: CBAY)
| Last Price | $6.99 |
| Net Change | $-0.21 (-2.92%) |
| Bid | $6.8 |
| Ask Price | $7.27 |
| Open Price | $7.22 |
| Previous Close Price | $7.2 |
| High Price | $7.35 |
| Low Price | $6.81 |
| Number of Trades | 2,223 |
| Volume | 710,700 |
| Fifty Two Week High | $8.29 (2017-07-27) |
| Fifty Two Week Low | $1.15 (2016-11-09) |
| Average Daily Volume | 714,113 |
| Share Outstanding | 43,760 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $ () |
| 2nd Quarter Earnings | $ () |
| 3nd Quarter Earnings | $ () |
| 4th Quarter Earnings | $ () |
| PE Ratio | $0 |
| EPS Growth | $29.65 |
| Recent Earnings | $ |
| Annual EPS | $-1.05 |
| Last Quarter EPS | $ |
| Market Capitalization | $0.31B |
| Insider Shareholders % | 0.151% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 43,760 |
| Inst. Shareholder % | 25.8% |
| Annual Net Income | $-0.03B |
| TTM Net Profit Margin | $-565.97 |
| 1-Year Return | 253.03% |
| 3-Year Return | 1.9% |
| 5-Year Return | -22.33% |
| 5-Year Revenue Growth | 0% |
| 5-Year Earnings Growth | 0% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | 29.65% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 2.13 |